The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Review of Natural Compounds for Potential Skin Cancer Treatment
Open accessAbstract
Most anti-cancer drugs are derived from natural resources such as marine, microbial and botanical sources. Cutaneous malignant melanoma is the most aggressive form of skin cancer, with a high mortality rate. Various treatments for malignant melanoma are available, but due to the development of multi-drug resistance, current or emerging chemotherapies have a relatively low success rates. This emphasizes the importance of discovering new compounds that are both safe and effective against melanoma. In vitro testing of melanoma cell lines and murine melanoma models offers the opportunity for identifying mechanisms of action of plant derived compounds and extracts. Common anti-melanoma effects of natural compounds include potentiating apoptosis, inhibiting cell proliferation and inhibiting metastasis. There are different mechanisms and pathways responsible for anti-melanoma actions of medicinal compounds such as promotion of caspase activity, inhibition of angiogenesis and inhibition of the effects of tumor promoting proteins such as PI3-K, Bcl-2, STAT3 and MMPs. This review thus aims at providing an overview of anti-cancer compounds, derived from natural sources, that are currently used in cancer chemotherapies, or that have been reported to show anti-melanoma, or anti-skin cancer activities. Phytochemicals that are discussed in this review include flavonoids, carotenoids, terpenoids, vitamins, sulforaphane, some polyphenols and crude plant extracts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–219 of 219
Ultraviolet Radiation and the Skin: An In-Depth Review
Morganroth, P. A., Lim, H. W., & Burnett, C. T. (2012) · American Journal of Lifestyle Medicine · doi:10.1177/1559827612460499 · Cited by 25
Philips, N. E., Keller, T., & Holmes, C. E. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.05.009 · Cited by 25
Nartey, L., Huwiler, K., Shang, A., Liewald, K., Jüni, P., & Egger, M. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.11.018 · Cited by 25
Advising Patients on the Use of Complementary and Alternative Medicine
Jonas, W. B. (2001) · Applied Psychophysiology and Biofeedback · doi:10.1023/a:1011398120476 · Cited by 24
Management of superficial basal cell carcinoma: focus on imiquimod
Raasch, B. (2009) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s3507 · Cited by 24
Guruvayoorappan, C., & Kuttan, G. (2007) · Nutrition Research · doi:10.1016/j.nutres.2007.04.009 · Cited by 24
The Effect of Submicron Emulsion Systems on Transdermal Delivery of Kaempferol
Chao, Y. Y., Huang, C., Fu, L.-T., Huang, Y., Tsai, Y., & Wu, P. (2012) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c12-00372 · Cited by 22
Alpinia oxyphylla Miq. bioactive extracts from supercritical fluid carbon dioxide extraction
Lee, C., Chiu, C., Liao, W., Wu, P., Chen, Y., Huang, K., Chou, Y., Wen, Z., & Wang, H. (2013) · Biochemical Engineering Journal · doi:10.1016/j.bej.2013.03.009 · Cited by 21
Silencing and re‐expression of retinoic acid receptor beta2 in human melanoma
Fan, J., Eastham, L. L., Varney, M. E., Hall, A., Adkins, N. L., Sollars, V. E., Georgel, P., & Niles, R. M. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00702.x · Cited by 20
Thornton, M., Parry, M., Gill, P., Mead, D., & Macbeth, F. R. (2011) · International Journal of Palliative Nursing · doi:10.12968/ijpn.2011.17.2.68 · Cited by 18
Ribeiro, M. P. C., Silva, F. S. G., Paixão, J., Santos, A. E., & Custódio, J. B. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.038 · Cited by 18
Portrayal of Complementary and Alternative Medicine for Cancer by Top Online News Sites
Price, A., & Grann, V. R. (2012) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2011.0110 · Cited by 15
Dehydroleucodine and dehydroparishin-B inhibit proliferation and motility of B16 melanoma cells
Priestap, H. A., Galvis, A., Rivero, N., Costantino, V., López, L. A., & Barbieri, M. A. (2012) · Phytochemistry Letters · doi:10.1016/j.phytol.2012.05.018 · Cited by 14
Modulation of Photochemical Damage in Normal and Malignant Cells by Naturally Occurring Compounds†
Lee, Y., Kumar, N., & Glickman, R. D. (2012) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2012.01156.x · Cited by 13
Why vitamin D for cancer patients?
Gandini, S., Francesco, F. D., Johanson, H., Bonanni, B., & Testori, A. (2010) · ecancermedicalscience · doi:10.3332/ecancer.2009.160 · Cited by 13
A novel mechanism of filaggrin induction and sunburn prevention by β-damascenone in Skh-1 mice
Uddin, A., Labuda, I., & Burns, F. J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.08.035 · Cited by 12
The Microarray Expression Analysis Identifies BAX as a Mediator of β-Carotene Effects on Apoptosis
Bodzioch, M., Dembinska-Kiec, A., Hartwich, J., Lapicka-Bodzioch, K., Banaś-Ząbczyk, A., Polus, A., Grzybowska, J., Wybrańska, I., Dulińska, J., Gil, D., et al. (2005) · Nutrition and Cancer · doi:10.1207/s15327914nc5102_13 · Cited by 11
Ottino, P., & Duncan, J. R. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90052-6 · Cited by 9
Beyond Randomized Controlled Trials: Evidence in Complementary Medicine
Golden, I. (2012) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587211429351 · Cited by 4
Cited by
Hasan, N., Nadaf, A., Imran, M., Jiba, U., Sheikh, A., Almalki, W. H., Almujri, S. S., Mohammed, Y. H., Kesharwani, P., & Ahmad, F. J. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01854-3 · Cited by 322
Do We Utilize Our Knowledge of the Skin Protective Effects of Carotenoids Enough?
Balić, A., & Mokos, M. (2019) · Antioxidants · doi:10.3390/antiox8080259 · Cited by 104
Nowak, A., Zielonka-Brzezicka, J., Perużyńska, M., & Klimowicz, A. (2022) · Molecules · doi:10.3390/molecules27113536 · Cited by 17
Metadata
- Authors
- Chinembiri, T., Du Plessis, L., Gerber, M., Hamman, J., & Du Plessis, J.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2014-08-06
- Volume
- 19
- Issue
- 8
- Pages
- 11679-11721
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2025055344
- Cited by
- 270
- References
- 219
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
